Company Information

Company Duopharma Biotech Berhad
duopharmabiotech.com
Type:
Company
Country:
Malaysia
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
13 April 2020
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024

Communication On Progress

Published On Title Level/Status
12-May-2022 Communication on Progress Advanced
14-May-2021 Communication on Progress (Duopharma Biotech Berhad) Advanced
12-Apr-2021 Grace Letter Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.